-
2023 First Generic Drug Approvals
08 Mar 2024 22:36 GMT
… Package
B. Braun Medical, Inc.
Calcium Gluconate … once-daily, maintenance treatment of bronchospasm associated …
Aspiro Pharma Limited
Bridion (Sugammadex) Injection
6 … 0.064%
Glenmark Pharmaceuticals LimitedGlenmark Pharmaceuticals Limited
Enstilar ( …
-
The biotech $100-billion Club: Meet the 14 most valuable drug makers
05 Mar 2024 23:47 GMT
… S. Food and Drug Administration (FDA) for the treatment of one-year- … -drug conjugates for cancer, among others.
Vertex Pharmaceuticals – $112 billion
The American biotech … , Bridion, Adempas, Lagevrio, Belsomra, Simponi, and Januvia, as well as vaccines such …
-
Merck’s Bridion Could Face Generic Pressure from Hikma Ahead of Patent Expiry Date
27 Feb 2024 13:37 GMT
… Monday that Hikma Pharmaceuticals U.S. is seeking the FDA’s approval … relaxant reversal injection Bridion (sugammadex) prior to the drug’s patent expiration … new and innovative treatments to patients with unmet medical needs.
Tristan Manalac …
-
Merck's Bridion faces generic threat from drugmaker Hikma
26 Feb 2024 23:13 GMT
… received a letter that Hikma Pharmaceuticals US unit has sought … FDA to sell a generic version of its Bridion injection, the drugmaker … related to the brand-name drug.
Merck said in the … to Reuters requests for comment. Bridion, chemically known as sugammadex, …
-
Merck 4Q Growth Driven by Oncology, Vaccines
05 Feb 2024 18:07 GMT
… $14.5 billion (-97%)
Comments: Pharmaceutical sales were $13.1 billion … driven by growth in oncology, vaccines and hospital acute care, … virology, due to COVID-19 vaccine LAGEVRIO, and diabetes. LAGEVRIO … pricing in the U.S. BRIDION sales were $429 million, …
-
20 Most Expensive Drugs in the World
28 Dec 2023 03:40 GMT
… drugs for numerous treatments, resulting in the expansion of the pharmaceutical drug … biotech companies, Roche Holding AG (ROG.SW) focuses on creating medicines … for the HPV vaccine in China. Additionally, … anti-muscle relaxant Bridion, reaching $1.7 billion …
-
Merck Secures Bridion Patent Protection Through January 2026
15 Jun 2023 15:24 GMT
… muscle relaxant reversal medicine Bridion (sugammadex).
In the medical and pharmaceutical industry, patents are … a drug candidate or investigational device goes through the FDA’s … new and innovative medicines and vaccines to address unmet medical needs and …
-
Merck gets a patent win for muscle relaxant reversal drug
14 Jun 2023 21:48 GMT
… keep marketing a blockbuster surgery drug until early 2026.
The pharma … a new drug.
“We look forward to continuing to provide Bridion to …
-
US District Court rules in favour of Merck in patent infringement lawsuit related to Bridion
15 Jun 2023 05:24 GMT
… the primary patent related to Bridion (sugammadex). Patent Term Extension … regulatory review process for new drugs.
Today’s ruling from … US patent protection for Bridion through at least January … important new therapies and vaccines forward to the patients …
-
U.S. District Court for the District of New Jersey Rules in Favor of Merck in Patent Infringement Lawsuit Related to BRIDION® (sugammadex)
13 Jun 2023 20:36 GMT
… the primary patent related to BRIDION® (sugammadex). Patent Term … the development of important medicines and vaccines. We aspire to … advance the prevention and treatment of diseases in people … 19); the impact of pharmaceutical industry regulation and health …